A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target for suppressing endothelial inflammation and atherosclerosis. Their work was published in Nature Cardiovascular Research.
Go to Source
https://medicalxpress.com/rss-feed/